Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1T 100 pari----1件: 299 💬
2T 614----1件: 300 💬
3T cell infusion----1件: 285 💬
4T cell injection targeting CD19 chimeric antigen receptor----6件: 46, 49, 51, 53, 93, 300 💬
5T cell injection targeting CD7 chimeric antigen receptor----1件: 51 💬
6T cell vaccination----1件: 13 💬
7T CELL-depleted donor lymphocyte infusion----1件: 60 💬
8T cells transduced with chimeric antigen receptor ANTI-CD19----1件: 49 💬
9T-326----1件: 299 💬
10T-52241件: T-5224---1件: 46 💬
11T-614----1件: 46 💬
12T-cell depleted & CD34+select/W/stemcell enriched product----1件: 65 💬
13T-cell vaccination----1件: 13 💬
14T-peptide-CRM197 conjugate----1件: 11 💬
15T0001----1件: 46 💬
16T100----1件: 299 💬
17T100 pari----1件: 299 💬
18T1401----1件: 240 💬
19T807----1件: 127 💬
20TA-461件: Recifercept1件: Recifercept 💬 1件: FGFR3 💬 12件: Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬1件: 276 💬
21TA-650----4件: 37, 56, 96, 97 💬
22TA-650 10 MG/KG----1件: 46 💬
23TA-650 3 MG/KG----1件: 46 💬
24TA-650 6 MG/KG----1件: 46 💬
25TAB08----2件: 46, 49 💬
26Tabalumab1件: Tabalumab1件: Tabalumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
27Tabalumab AUTO-injector1件: Tabalumab1件: Tabalumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
28Tabalumab prefilled syringe1件: Tabalumab1件: Tabalumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
29Tabelecleucel1件: Tabelecleucel1件: Tabelecleucel 💬 --1件: 65 💬
30Tachipirina - 500 MG compresse10 compresse----1件: 28 💬
31Tachipirina - 500 MG compresse20 compresse----1件: 13 💬
32Taci - FC5----1件: 46 💬
33TACI-FC51件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬 		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 46, 49 💬
34Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬31件: 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
35Tacrolimus and MMF1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
36Tacrolimus capsule1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
37Tacrolimus capsules1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 299 💬
38Tacrolimus combined with prednisone1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
39Tacrolimus FOR THE treatment OF IMN1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
40Tacrolimus lipid suspension FOR enema1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
41Tacrolimus ointment1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 56 💬
42Tacrolimus prolonged-release hard capsules1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
43Tacrolimus with methotrexate1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
44TAD----1件: 299 💬
45TAD 600----1件: 299 💬
46Tadalafil1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬7件: 6, 51, 75, 77, 84, 86, 113 💬
47Tadalafil 20 MG1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113 💬
48Tadalafil 20 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
49Tadalafil 40 MG1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
50Tadalafil and ambrisentan upfront combination therapy1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
51Tadalafil and sildenafil1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113 💬
52Tadalafil citrate1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 210 💬
53Tadalafil mimic1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
54Tadalafil oral suspension1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
55Tadalafil- tablet or oral suspension1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
56Tadalafilo1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
57Tadekinig alfa1件: Tadekinig alfa---2件: 54, 65 💬
58Tafamidis1件: Tafamidis2件: Tafamidis ,
Tafamidis meglumine 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
59Tafamidis meglumine1件: Tafamidis2件: Tafamidis ,
Tafamidis meglumine 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
60Tafamidis meglumine 20 MG soft gelatin capsules1件: Tafamidis2件: Tafamidis ,
Tafamidis meglumine 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
61Tafasitamab1件: Tafasitamab1件: Tafasitamab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 51 💬
62Tafluprost1件: Tafluprost1件: Tafluprost 💬 1件: PTGFR 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 299 💬
63Tailored diet----1件: 66 💬
64TAK-007----1件: 51 💬
65TAK-018----1件: 96 💬
66TAK-0711件: TAK-071---1件: 6 💬
67TAK-079----3件: 11, 49, 63 💬
68TAK-279----3件: 37, 96, 97 💬
69TAK-341----1件: 17 💬
70TAK-411----1件: 14 💬
71TAK-4751件: TAK-475---1件: 79 💬
72TAK-577----1件: 288 💬
73TAK-625----2件: 297, 338 💬
74TAK-667----1件: 65 💬
75TAK-672----1件: 288 💬
76TAK-675----1件: 19 💬
77TAK-7151件: TAK-715---1件: 46 💬
78TAK-715 and methotrexate2件: Methotrexate,
TAK-715		2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
79TAK-743, SHP643, DX-2930----1件: 65 💬
80TAK-755----1件: 64 💬
81TAK-755 or BAX930 or SHP655----1件: 64 💬
82TAK-755 orbax930 or SHP655----1件: 64 💬
83TAK-771----2件: 14, 65 💬
84TAK-783----1件: 46 💬
85TAK-783 and methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
86TAK-831----1件: 18 💬
87TAK-881----2件: 14, 65 💬
88TAK-935----2件: 140, 144 💬
89TAK-999, ARO-AAT1件: Fazirsiran---1件: 231 💬
90TAK743----1件: 65 💬
91Takhzyro1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
92Taking OF blood----1件: 113 💬
93Taking peripheral blood samples----1件: 49 💬
94Taladegib1件: Taladegib1件: Taladegib 💬 1件: SMO 💬 5件: Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬1件: 85 💬
95Talampanel1件: Talampanel1件: Talampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		17件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬2件: 2, 6 💬
96Taldefgrobep alfa1件: Talditercept alfa1件: Taldefgrobep alfa 💬 1件: MSTN 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 3 💬
97Taldefgrobep alfa 1件: Talditercept alfa1件: Taldefgrobep alfa 💬 1件: MSTN 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 3 💬
98Talfirastide----1件: 113 💬
99Taliglucerase alfa1件: Taliglucerase alfa1件: Taliglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
100Taliglucerase alfa - recombinant human glucocerebrosidase1件: Taliglucerase alfa1件: Taliglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
101Talineuren----1件: 6 💬
102Tallampanel----1件: 2 💬
103Talniflumate1件: Talniflumate1件: Talniflumate 💬 --1件: 299 💬
104Talquetamab1件: Talquetamab1件: Talquetamab 💬 1件: CD3E 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 28 💬
105Taltz 80MG1件: Ixekizumab1件: Ixekizumab 💬 1件: IL17A 💬 6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 36 💬
106Tamibarotene1件: Tamibarotene1件: Tamibarotene 💬 1件: RARA 💬 5件: Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬3件: 26, 67, 96 💬
107Tamox----1件: 113 💬
108Tamoxifen1件: Tamoxifen2件: Tamoxifen citrate ,
Tamoxifen 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬4件: 2, 86, 113, 227 💬
109Tamoxifen 20MG hexal® filmtabletten1件: Tamoxifen2件: Tamoxifen citrate ,
Tamoxifen 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
110Tamoxifen 40 MG daily FOR ONE year1件: Tamoxifen2件: Tamoxifen citrate ,
Tamoxifen 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 2 💬
111Tamoxifen citrate1件: Tamoxifen2件: Tamoxifen citrate ,
Tamoxifen 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
112Tampa kinesiophobia scale, BERG-balance test, international physical activity questionnaire-short form, falls efficacy scale----1件: 6 💬
113Tamsulosin1件: Tamsulosin2件: Tamsulosin hydrochloride ,
Tamsulosin 💬 		3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13 💬
114Tanakan1件: Ginkgo biloba1件: Ginkgo 💬 --1件: 13 💬
115Tanezumab1件: Tanezumab1件: Tanezumab 💬 1件: NGFB 💬 9件: Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 226, 298 💬
116Tapering or discontinuation OF etanercept----1件: 271 💬
117TARA-002----1件: 278 💬
118Tarceva and rapamycin----1件: 34 💬
119Tarenflurbil1件: Tarenflurbil1件: Tarenflurbil 💬 4件: APH1,
NCSTN,
PSEN1,
PSENEN 💬 		6件: Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway 💬1件: 13 💬
120Targeted synthetic dmard class----1件: 46 💬
121Targinact 10 MG/5 MG prolonged-release tablets----2件: 6, 226 💬
122Targinact 20 MG/10 MG prolonged-release tablets----1件: 6 💬
123Targinact 20MG/10 MG prolonged-release tablets----1件: 226 💬
124Targinact 5 MG/2.5 MG prolonged-release tablets----1件: 6 💬
125Targinact 5MG/2.5 MG prolonged-release tablets----1件: 226 💬
126Targretin1件: Bexarotene1件: Bexarotene 💬 3件: RXRA,
RXRB,
RXRG 💬 		18件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 13 💬
127Tarpeyo 4 MG delayed release oral capsule----1件: 66 💬
128TAS-205----1件: 113 💬
129TAS5315 high dose----1件: 46 💬
130TAS5315 LOW dose----1件: 46 💬
131Tasigna1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 34, 86 💬
132Tasigna 150MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
133Tasigna 200MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
134Tasigna 50 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
135Tasigna® 150 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
136Tasimelteon1件: Tasimelteon1件: Tasimelteon 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
137Tasmar1件: Tolcapone1件: Tolcapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬2件: 6, 28 💬
138Tasocitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
139Tasocitinib citrate1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
140Tasocitinib plus methotrexate2件: Methotrexate,
Tofacitinib		4件: Methotrexate ,
Methotrexate sodium ,
Tofacitinib citrate ,
Tofacitinib 💬 		6件: DHFR,
DHFR,
JAK1,
JAK2,
JAK3,
TYK2 💬 		42件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Folate biosynthesis, Folate transport and metabolism, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
141Taste tests----1件: 6 💬
142Tasty&healthy intervention group----1件: 96 💬
143TAT4 GEL concentration A----1件: 265 💬
144TAT4 GEL concentration B----1件: 265 💬
145Taurine1件: Taurine1件: Taurine 💬 --4件: 13, 21, 201, 337 💬
146Taurolite----1件: 2 💬
147Tauroursodeoxycholic acid1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --2件: 2, 299 💬
148Tauroursodeoxycholic acid capsules1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 93 💬
149Tauroursoursodeoxycholic acid, brand name tudcabil----1件: 97 💬
150Taurursodiol1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 2 💬
151Tavapadon1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
152Tavapadon 0.25 MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
153Tavapadon 0.25MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
154Tavapadon 1MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
155Tavapadon 5 MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
156Tavapadon 5MG1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
157Tazarotene1件: Tazarotene1件: Tazarotene 💬 3件: RARA,
RARB,
RXRB 💬 		15件: Acute myeloid leukemia, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Lipid and atherosclerosis, Non-small cell lung cancer, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 85 💬
158Tazobactam1件: Tazobactam2件: Tazobactam ,
Tazobactam sodium 💬 		--1件: 299 💬
159Tazobactam sodium1件: Tazobactam2件: Tazobactam ,
Tazobactam sodium 💬 		--1件: 299 💬
160TB006----1件: 6 💬
161TBC----4件: 85, 94, 96, 127 💬
162TBD----5件: 19, 86, 90, 276, 299 💬
163TBE-vaccine----1件: 46 💬
164TBI----3件: 60, 65, 285 💬
165TBM100----1件: 299 💬
166TBM100C----1件: 299 💬
167TC 99M tilmanocept----1件: 46 💬
168TC-MSC----2件: 36, 107 💬
169TC99M tilmanocept----1件: 46 💬
170TC99M-tilmanocept----1件: 46 💬
171TCD after bosentan administration----1件: 13 💬
172TCD baseline----1件: 13 💬
173TCD601----1件: 2 💬
174Tcelna----1件: 13 💬
175TCH346----1件: 2 💬
176TCK-276----1件: 46 💬
177TCM (GAN-LU-YIN)GLY----1件: 53 💬
178TCP-25 GEL----1件: 36 💬
179TCP-25 GEL 0.86 MG/ML----1件: 36 💬
180TCP-25 GEL 2.9 MG/ML----1件: 36 💬
181TCP-25 GEL 8.6 MG/ML----1件: 36 💬
182TCR alfa beta T cell depletion----1件: 65 💬
183TD-1058----1件: 85 💬
184TD-1473----2件: 96, 97 💬
185TD-1473 dose A----1件: 97 💬
186TD-1473 dose B----1件: 97 💬
187TD-1473 dose C----1件: 97 💬
188TD-3504----1件: 97 💬
189TD-9855----2件: 6, 17 💬
190TD139----1件: 85 💬
191TDF/FTC/LPV/R----1件: 93 💬
192TDI01 suspension1件: TDI-01---1件: 85 💬
193TDM-based infliximab intravenous therapy----1件: 96 💬
194Tdmards----1件: 46 💬
195TE-8214 - SAD----1件: 77 💬
196TEA----1件: 46 💬
197TEA consumption----1件: 46 💬
198TEA extract1件: Green tea leaf1件: Green tea leaf 💬 --1件: 28 💬
199Tears naturale forte----1件: 53 💬
200Tecfidera1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
201Tecfidera - 240 MG - capsula rigida gastroresistente - USO orale - blister (PVC/PE/PVDC-PVC alluminio) - 56 capsule----1件: 13 💬
202Tecfidera 240MG CPS ETD1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
203Tecfidera® 120 MG1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
204Tecfidera® 120MG magensaftresistente hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
205Tecfidera® 240 MG1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
206Tecfidera® 240MG magensaftresistente hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
207Technetium (99MTC) exametazime----1件: 6 💬
208Technetium [TC-99M] sulfur colloid and indium [IN-111] dtpa----1件: 299 💬
209Technetium labelled glucosamine----2件: 46, 271 💬
210Technetium sulfur colloid----1件: 299 💬
211Technetium TC 99M1件: Technetium Tc-99m---1件: 98 💬
212Technetium TC 99M tilmanocept3件: Technetium Tc-99m,
Technetium Tc-99m tilmanocept,
Tilmanocept		---1件: 46 💬
213Technetium-99M1件: Technetium Tc-99m---1件: 28 💬
214Teclistamab1件: Teclistamab1件: Teclistamab 💬 2件: CD3E,
TNFRSF17 💬 		13件: Chagas disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 28 💬
215Tedizolid IV1件: Tedizolid1件: Tedizolid 💬 --1件: 299 💬
216Tedizolid PO1件: Tedizolid1件: Tedizolid 💬 --1件: 299 💬
217Teduglutide1件: Teduglutide1件: Teduglutide 💬 1件: GLP2R 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
218Teduglutide 0.05 dose1件: Teduglutide1件: Teduglutide 💬 1件: GLP2R 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
219Teduglutide 0.1 MG dose1件: Teduglutide1件: Teduglutide 💬 1件: GLP2R 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
220Teduglutide 0.2 MG1件: Teduglutide1件: Teduglutide 💬 1件: GLP2R 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
221Tefibazumab1件: Tefibazumab1件: Tefibazumab 💬 --1件: 299 💬
222Tegaderm----1件: 86 💬
223Tehalose 30GR----1件: 113 💬
224Teicoplanin1件: Teicoplanin1件: Teicoplanin 💬 --2件: 70, 299 💬
225Teicoplanina sandoz - 200 MG polvere E solvente PER soluzione iniettabile O infusione 1 flaconcino vetro DA 200 MG E 1 fiala vetro DA 3 ML1件: Teicoplanin1件: Teicoplanin 💬 --1件: 299 💬
226Teicoplanina sandoz 200 MG1件: Teicoplanin1件: Teicoplanin 💬 --1件: 299 💬
227Telavancin injection1件: Telavancin1件: Telavancin hydrochloride 💬 --1件: 299 💬
228Telephone-based cognitive behavioral therapy----1件: 13 💬
229Telerehabilitation based functional balance and mobility exercise----1件: 6 💬
230Telerehabilitation based lsvt BIG exercise protocol----1件: 6 💬
231Telitacicept1件: Telitacicept---11件: 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
232Telitacicept 160 MG1件: Telitacicept---1件: 53 💬
233Telitacicept 160MG1件: Telitacicept---2件: 49, 66 💬
234Telitacicept 240MG1件: Telitacicept---1件: 66 💬
235Telitacicept 80 MG1件: Telitacicept---1件: 53 💬
236Telitacicept tofacitinib1件: Telitacicept---1件: 46 💬
237Telitacicept+SOC1件: Telitacicept---1件: 48 💬
238Telitacicept-only group1件: Telitacicept---1件: 11 💬
239Telmisartan1件: Telmisartan1件: Telmisartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 67 💬
240Telomere length----1件: 46 💬
241Telotristat etiprate1件: Telotristat1件: Telotristat 💬 2件: TPH1_2,
TPH1_2 💬 		3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 97 💬
242TEM----2件: 299, 340 💬
243Temanogrel----1件: 51 💬
244Temelimab1件: Temelimab---1件: 13 💬
245Temerit----1件: 113 💬
246Temozolomide1件: Temozolomide1件: Temozolomide 💬 --2件: 34, 65 💬
247Temperature sensitivity measurement with advanced thermal stimulation----1件: 19 💬
248Temsirolimus1件: Temsirolimus1件: Temsirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬3件: 34, 89, 331 💬
249Temsirolimus tablets1件: Temsirolimus1件: Temsirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 13 💬
250Tenapanor1件: Tenapanor2件: Tenapanor ,
Tenapanor hydrochloride 💬 		1件: SLC9A3 💬 4件: Bile secretion, Mineral absorption, Protein digestion and absorption, Proximal tubule bicarbonate reclamation 💬2件: 6, 299 💬
251Tendon interposition arthroplasty----1件: 46 💬
252Tenofovir1件: Tenofovir1件: Tenofovir 💬 --3件: 13, 265, 325 💬
253Tenofovir alafenamide2件: Tenofovir,
Tenofovir alafenamide		3件: Tenofovir ,
Tenofovir alafenamide ,
Tenofovir alafenamide fumarate 💬 		--2件: 2, 13 💬
254Tenofovir DF1件: Tenofovir1件: Tenofovir 💬 --1件: 265 💬
255Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		4件: Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--1件: 93 💬
256Tenofovir disoproxil fumarate2件: Tenofovir,
Tenofovir disoproxil		4件: Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--2件: 6, 265 💬
257Tenofovir-emtricitabine1件: Tenofovir1件: Tenofovir 💬 --1件: 25 💬
258Tepezza----1件: 51 💬
259Terazosin1件: Terazosin2件: Terazosin hydrochloride ,
Terazosin 💬 		3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 6 💬
260Terazosin 5 MG1件: Terazosin2件: Terazosin hydrochloride ,
Terazosin 💬 		3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 6 💬
261Terazosin therapy1件: Terazosin2件: Terazosin hydrochloride ,
Terazosin 💬 		3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 6 💬
262Terbinafine1件: Terbinafine2件: Terbinafine hydrochloride ,
Terbinafine 💬 		--2件: 96, 97 💬
263Terbinafine tablets1件: Terbinafine2件: Terbinafine hydrochloride ,
Terbinafine 💬 		--2件: 97, 271 💬
264Terbutaline1件: Terbutaline2件: Terbutaline sulfate ,
Terbutaline 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 118 💬
265Terguride1件: Terguride1件: Terguride 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51 💬
266Terguride 0,5MG tablet1件: Terguride1件: Terguride 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 86 💬
267Terguride 0.5 MG tablet1件: Terguride1件: Terguride 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 86 💬
268Terguride hydrogenmaleate1件: Terguride1件: Terguride 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51 💬
269Teriflunomide1件: Teriflunomide1件: Teriflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬4件: 13, 25, 26, 63 💬
270Teriflunomide 14 MG1件: Teriflunomide1件: Teriflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 13 💬
271Teriflunomide capsule1件: Teriflunomide1件: Teriflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 13 💬
272Teriflunomide HMR17261件: Teriflunomide1件: Teriflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 13 💬
273Teriparatide1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬7件: 46, 68, 70, 71, 172, 235, 274 💬
274Teriparatide conjugated TO A multiarm polyethylene glycol carrier molecule through A cleava1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
275Teriparatide conjugated TO A multiarm polyethylene glycol carrier molecule through A cleavable linker1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
276Teriparatide PEN injector1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 274 💬
277Terlipressin acetate1件: Terlipressin2件: Terlipressin ,
Terlipressin acetate 💬 		3件: AVPR1A,
AVPR1B,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 299 💬
278Tesamorelin1件: Tesamorelin2件: Tesamorelin ,
Tesamorelin acetate 💬 		1件: GHRHR 💬 3件: Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 265 💬
279Tesevatinib1件: Tesevatinib1件: Tesevatinib 💬 5件: EGFR,
EPHB4,
ERBB2,
FLT4,
KDR 💬 		51件: Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway, Virion - Hepatitis viruses 💬1件: 67 💬
280Tesofensine1件: Tesofensine---2件: 6, 193 💬
281Tesofensine citrate1件: Tesofensine---1件: 193 💬
282Tesofensine/metoprolol1件: Tesofensine---1件: 193 💬
283Tesomet----1件: 193 💬
284Test group (group A): FCN-159 8 MG, orally, once daily----1件: 34 💬
285Test product----1件: 46 💬
286Test soda----1件: 299 💬
287Testing OF autonomous nervous system function----1件: 13 💬
288Testogel----1件: 78 💬
289Testosterone1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬6件: 1, 2, 3, 13, 76, 113 💬
290Testosterone decanoate2件: Testosterone,
Testosterone decanoate		2件: Testosterone ,
Testosterone decanoate 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113 💬
291Testosterone enanthate2件: Testosterone,
Testosterone enanthate		2件: Testosterone ,
Testosterone enanthate 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113 💬
292Testosterone injection1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 265 💬
293Testosterone isocaproate2件: Testosterone,
Testosterone isocaproate		1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113 💬
294Testosterone phenylpropionate2件: Testosterone,
Testosterone phenylpropionate		2件: Testosterone ,
Testosterone phenylpropionate 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113 💬
295Testosterone plus somatropin1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 78 💬
296Testosterone propionate2件: Testosterone,
Testosterone propionate		2件: Testosterone ,
Testosterone propionate 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113 💬
297Testosterone undecanoate2件: Testosterone,
Testosterone undecanoate		2件: Testosterone ,
Testosterone undecanoate 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 13, 60 💬
298Teta 4HCL1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
299Teta.4HCI1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
300Teta.4HCL1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
301Tetanus + pnemococcal vaccines alone----1件: 46 💬
302Tetanus diphtheria toxoids vaccine----1件: 13 💬
303Tetanus protein----1件: 50 💬
304Tetanus toxoid1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬 		--3件: 13, 14, 46 💬
305Tetanus toxoid adsorbed booster vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬 		--1件: 46 💬
306Tetanus toxoid adsorbed vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬 		--1件: 46 💬
307Tetanus toxoid vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬 		--1件: 13 💬
308Tetanus vaccin----1件: 11 💬
309Tetanus, diphtheria, and acellular pertussis vaccine----1件: 13 💬
310Tetomilast1件: Tetomilast---2件: 96, 97 💬
311Tetrabenazine1件: Tetrabenazine1件: Tetrabenazine 💬 1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
312Tetrabenazine withdrawal1件: Tetrabenazine1件: Tetrabenazine 💬 1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
313Tetraccycline-hydrochloride----1件: 46 💬
314Tetracosactide acetate1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 83, 145 💬
315Tetracosactide esacetato1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113 💬
316Tetracosactide hexaacetate1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113 💬
317Tetracosactide hexacetaat1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222 💬
318Tetracosactin----1件: 67 💬
319Tetracosactrin1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78 💬
320Tetract-HIB - 1 siringa precaricata 0.5 ML----2件: 62, 222 💬
321Tetracyclin1件: Tetracycline2件: Tetracycline ,
Tetracycline hydrochloride 💬 		--1件: 36 💬
322Tetracycline1件: Tetracycline2件: Tetracycline ,
Tetracycline hydrochloride 💬 		--5件: 13, 46, 53, 66, 97 💬
323Tetracycline - statin - antimycotic1件: Tetracycline2件: Tetracycline ,
Tetracycline hydrochloride 💬 		--1件: 13 💬
324Tetrahydro-6,6,9-TRI methyl-3-penthyl-6 H-dibenzo[ B,D ]pyran-1-OL----1件: 298 💬
325Tetrahydrobiopterin1件: Sapropterin2件: Sapropterin dihydrochloride ,
Sapropterin 💬 		--1件: 240 💬
326Tetrahydrocannabinol1件: Dronabinol1件: Dronabinol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 8, 13, 298 💬
327Tetrandrine1件: Tetrandrine---1件: 46 💬
328Tetrathiomolybdate1件: Tetrathiomolybdate---3件: 85, 93, 171 💬
329TEV-48574----2件: 96, 97 💬
330TEV-48574 dose regimen A----2件: 96, 97 💬
331TEV-48574 dose regiment B----2件: 96, 97 💬
332TEV-56286----1件: 17 💬
333Tevagrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 2 💬
334TEZ----1件: 299 💬
335TEZ/IVA----1件: 299 💬
336Teza----1件: 299 💬
337Tezacaftor1件: Tezacaftor1件: Tezacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
338Tezacaftor/ivacaftor2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
339Tezacaftor/ivacaftor + ivacaftor1件: Tezacaftor1件: Tezacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
340Tezacaftor/ivacaftor 100MG/150MG2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
341Tezacaftor/ivacaftor/100MG/150MG2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
342Tezepelumab1件: Tezepelumab1件: Tezepelumab 💬 1件: TSLP 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬3件: 44, 45, 98 💬
343Tezepelumab apfs1件: Tezepelumab1件: Tezepelumab 💬 1件: TSLP 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98 💬
344Tezepelumab VIA apfs1件: Tezepelumab1件: Tezepelumab 💬 1件: TSLP 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98 💬
345Tezosentan1件: Tezosentan---1件: 86 💬
346TG-1101----1件: 13 💬
347Tgaac94 gene therapy vector1件: TGAAC94---2件: 46, 271 💬
348Tgaavcf1件: tgAAVCF---1件: 299 💬
349TGF-beta receptor TYPE-2 extracellular domain fused TO human IGG1 FC domain----1件: 51 💬
350TGF-beta receptor TYPE-2 fused TO human IGG1 FC domain----1件: 51 💬
351TGF-beta recettore DI T----1件: 51 💬
352TGF-beta recettore DI tipo II extracellulare, collegata A UN dominio FC umano modificato dell’immuno----1件: 51 💬
353TH-SC01----1件: 96 💬
354TH9507----1件: 265 💬
355THA----2件: 46, 271 💬
356Thalidomide1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
357Thalidomide 100MG1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
358Thalidomide 150MG1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
359Thalidomide celgene - 50 MG capsula rigida - USO orale - blister (PVC/PE/aclar/ALU) 28 capsule1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
360Thalidomide celgene*28CPS 50MG1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 227 💬
361Thalidomide pharmion1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 85, 96, 97 💬
362Thalidomide pill1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
363Thalidomide, cyclophosphamide and prednisone1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331 💬
364Tham----1件: 299 💬
365THC----3件: 8, 13, 36 💬
366THC 5MG/ML and CBS 50MG/ML----1件: 96 💬
367THE 0.5 ML dose OF vaccine contains 25 micrograms OF each OF THE following 23 pneumococcal polysaccharide----1件: 222 💬
368THE center FOR neurologic studies bulbar function scale----1件: 2 💬
369THE center FOR neurologic study bulbar function scale----1件: 2 💬
370THE clinimacs device----1件: 285 💬
371THE comprehensive treatment regimen OF traditional chinese medicine----1件: 222 💬
372THE conventional balance exercise program----1件: 6 💬
373THE effectiveness OF xeljanz IN rheumatoid arthritis patients----1件: 46 💬
374THE generic name IS warfarin and many producers will BE involved1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 49 💬
375THE GUT mycobiota and microbiota profile----1件: 299 💬
376THE immunosuppressive agents----1件: 222 💬
377THE investigational medicinal product (IMP) will BE labeled AS PF-04236921 106 MG/vial, clonal SC lyophilized form, which IS equivalent TO PF-04236921 powder FOR injection, 106 MG/vial AS described IN THE enclosed CTA----1件: 96 💬
378THE lung mycobiota and microbiota profile----1件: 299 💬
379THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire----1件: 149 💬
380THE standard steroid treatment, plasma exchange and rituximab----1件: 85 💬
381THE study drug IS SHED-CM manufactured BY U-factor----1件: 2 💬
382THE timed 360° turn test----1件: 6 💬
383THE YI-QI-QING-JIE herbal compound----1件: 66 💬
384Thecaflex DRX system----1件: 3 💬
385Thelin1件: Sitaxentan2件: Sitaxentan ,
Sitaxentan sodium 💬 		1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
386Theophylline1件: Theophylline3件: Theophylline ,
Theophylline ,
Theophylline sodium glycinate 💬 		18件: ADORA1,
ADORA2B,
PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬 		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 236, 299 💬
387Theophylline ER1件: Theophylline3件: Theophylline ,
Theophylline ,
Theophylline sodium glycinate 💬 		18件: ADORA1,
ADORA2B,
PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬 		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 236 💬
388Theracurmin HP----1件: 2 💬
389Theraderm----1件: 78 💬
390Therapeutic allogeneic lymphocytes1件: Therapeutic allogeneic lymphocytes---3件: 60, 65, 285 💬
391Therapeutic drug monitoring (TDM) OF adalimumab----1件: 46 💬
392Therapeutic immune globulin----1件: 205 💬
393Therapy education----1件: 97 💬
394There IS NO recommended INN----1件: 65 💬
395Therm-apptm TH, thermographic camera----1件: 70 💬
396Thetanix----1件: 96 💬
397Thiamin1件: Thiamine3件: Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--1件: 97 💬
398Thiamine1件: Thiamine3件: Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--3件: 13, 93, 265 💬
399Thiazide----1件: 235 💬
400Thioplex----1件: 13 💬
401Thiopurine----2件: 96, 97 💬
402Thiosix----2件: 96, 97 💬
403Thiotepa1件: Thiotepa1件: Thiotepa 💬 --11件: 13, 28, 46, 51, 60, 65, 85, 96, 107, 284, 285 💬
404Thiotepa--escalated dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
405Thiotepa--single daily dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
406Thiscart19A----1件: 61 💬
407THK-53511件: THK-5351---5件: 5, 6, 7, 17, 127 💬
408THK5351----4件: 5, 6, 7, 17 💬
409THN02----1件: 6 💬
410THN102 dosage A----1件: 6 💬
411THN102 dosage B----1件: 6 💬
412THN102 dosage C----1件: 6 💬
413Thoracic CT scan----1件: 229 💬
414Threonine1件: Threonine1件: Threonine 💬 --3件: 86, 96, 97 💬
415Thrombomodulin alfa1件: Thrombomodulin Alfa1件: Thrombomodulin alfa 💬 1件: F2 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬1件: 85 💬
416Thrombopoietin1件: Thrombopoietin---2件: 47, 63 💬
417Thrombopoietin receptor agonist1件: Thrombopoietin---1件: 61 💬
418THRX-139060----2件: 96, 97 💬
419THRX-199687 hydrochloride----1件: 99 💬
420Thymafalsin----1件: 65 💬
421Thymalfasin1件: Thymalfasin1件: Thymalfasin 💬 --1件: 65 💬
422Thymectomy plus prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 11 💬
423Thymic shielding during radiation----1件: 285 💬
424Thymoglobulin1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬6件: 36, 51, 60, 96, 285, 326 💬
425Thymoglobuline1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬5件: 13, 36, 51, 60, 96 💬
426Thymoglobuline - 5 MG/ML polvere PER concentrato PER soluzione PER infusione 1 fiala DA 10 ML1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬1件: 51 💬
427Thymoglobuline 5 MG/ML, poudre pour solution pour perfusion1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬1件: 60 💬
428Thymol1件: Thymol1件: Thymol 💬 --1件: 13 💬
429Thymosin alpha 1----1件: 299 💬
430Thymosin beta 41件: Thymosin beta-4---1件: 36 💬
431Thymosin beta 4 EYE drops1件: Thymosin beta-4---1件: 53 💬
432Thymus tissue FOR transplantation----1件: 65 💬
433Thymus/parathyroid transplantation----2件: 65, 235 💬
434Thyroid sonography----1件: 77 💬
435Thyrotropin releasing hormone2件: Protirelin,
Thyrotropin		1件: Protirelin 💬 1件: TRHR 💬 3件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 80 💬
436Thyroxin, triiodothyronine----1件: 78 💬
437Tiamin DAK----2件: 93, 97 💬
438Tiamin SAD----2件: 93, 97 💬
439Tiapridal----1件: 8 💬
440Tibulizumab1件: Tibulizumab1件: Tibulizumab 💬 2件: IL17A,
TNFSF13B 💬 		8件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬2件: 51, 53 💬
441Ticagrelor1件: Ticagrelor1件: Ticagrelor 💬 1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬1件: 46 💬
442Ticilimumab1件: Tremelimumab1件: Tremelimumab 💬 1件: CTLA4 💬 4件: Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬1件: 96 💬
443Tideglusib1件: Tideglusib---3件: 2, 5, 113 💬
444Tigecycline1件: Tigecycline1件: Tigecycline 💬 --1件: 93 💬
445Tildacerfont1件: Tildacerfont1件: Tildacerfont 💬 1件: CRHR1 💬 5件: Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
446Tildrakizumab1件: Tildrakizumab1件: Tildrakizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 271 💬
447Tildrakizumab 100 MG/ML1件: Tildrakizumab1件: Tildrakizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 271 💬
448Tildrakizumab prefilled syringe1件: Tildrakizumab1件: Tildrakizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 162 💬
449Tilmanocept1件: Tilmanocept---1件: 46 💬
450Tilpisertib1件: Tilpisertib---1件: 97 💬
451Tilpisertib fosmecarbil2件: Tilpisertib,
Tilpisertib fosmecarbil		---1件: 97 💬
452Time and attention + active fructooligosaccharide supplementation----2件: 96, 97 💬
453Time delay treatment OF botulinum toxin----1件: 149 💬
454Time interval between eswl and ercp IS 12H----1件: 298 💬
455Time interval between eswl and ercp IS greater than 12H----1件: 298 💬
456Time restricted olive OIL based (troo) ketogenic diet----1件: 13 💬
457Timed UP AN GO test----1件: 13 💬
458Timed UP and GO test----1件: 6 💬
459Timolol1件: Timolol3件: Timolol ,
Timolol maleate ,
Timolol 💬 		2件: ADRB1,
ADRB2 💬 		13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 157 💬
460Timolol alcon 0.5% collyre1件: Timolol3件: Timolol ,
Timolol maleate ,
Timolol 💬 		2件: ADRB1,
ADRB2 💬 		13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
461Timolol GEL1件: Timolol3件: Timolol ,
Timolol maleate ,
Timolol 💬 		2件: ADRB1,
ADRB2 💬 		13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
462Timolol maleate1件: Timolol3件: Timolol ,
Timolol maleate ,
Timolol 💬 		2件: ADRB1,
ADRB2 💬 		13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
463Timolol nasal spray1件: Timolol3件: Timolol ,
Timolol maleate ,
Timolol 💬 		2件: ADRB1,
ADRB2 💬 		13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
464Timrepigene emparvovec1件: Timrepigene emparvovec---1件: 90 💬
465TIN mesoporphyrin1件: Stannsoporfin1件: Stannsoporfin 💬 2件: HMOX1,
HMOX2 💬 		9件: Chemical carcinogenesis - reactive oxygen species, Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin metabolism 💬1件: 254 💬
466Tinlarebant1件: Tinlarebant1件: Tinlarebant 💬 --1件: 301 💬
467Tioctic acid----1件: 2 💬
468Tiomolibdic acid----1件: 171 💬
469Tiotropium1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬2件: 55, 85 💬
470Tiotropium bromide1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
471Tiotropium bromide 5 MCG1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
472Tiotropium bromide high1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
473Tiotropium bromide LOW1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
474Tiotropium bromide medium1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
475Tiotropium bromide monohydrate1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
476Tiotropium bromide-LOW DOSE-2.5MCG1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
477Tiotropium respimat1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
478Tiotropium respimat 1.25 microgram solution FOR inhalation1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
479Tiotropium respimat 1.25 microgram, solution FOR inhalation1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
480Tiotropium respimat 1.25 micrograms solution FOR inhalation1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
481Tiotropium respimat® inhaler1件: Tiotropium1件: Tiotropium bromide hydrate 💬 1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 299 💬
482TIP----1件: 299 💬
483Tipelukast1件: Tipelukast1件: Tipelukast 💬 1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 85 💬
484Tipifarnib1件: Tipifarnib1件: Tipifarnib 💬 2件: FNTA,
FNTB 💬 		1件: Terpenoid backbone biosynthesis 💬1件: 34 💬
485Tipranavir1件: Tipranavir2件: Tipranavir disodium ,
Tipranavir 💬 		--1件: 265 💬
486Tirabrutinib1件: Tirabrutinib2件: Tirabrutinib hydrochloride ,
Tirabrutinib 💬 		1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 46, 53 💬
487Tirasemtiv1件: Tirasemtiv1件: Tirasemtiv 💬 --1件: 2 💬
488Tiratricol1件: Tiratricol1件: Tiratricol 💬 2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 139 💬
489Tirzepatide1件: Tirzepatide1件: Tirzepatide 💬 2件: GIPR,
GLP1R 💬 		4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 67, 96, 97, 193, 233 💬
490TIS or TIP----1件: 299 💬
491Tissucol DUO (5.0ML) fibrin tissue adhesive----1件: 97 💬
492Tissue biopsy----1件: 1 💬
493Tissue donation after routine clinical procedure----2件: 89, 158 💬
494Tissue sample----1件: 49 💬
495Tissue samplings----1件: 6 💬
496Tissue selective estrogen complex----1件: 13 💬
497Titanium1件: Titanium---2件: 69, 70 💬
498Titanium cage1件: Titanium---1件: 70 💬
499Tiva----1件: 70 💬
500Tivanisiran sodium ophthalmic solution1件: Tivanisiran---1件: 53 💬
501Tividenofusp alfa1件: Tividenofusp alfa1件: Tividenofusp alfa 💬 2件: IDS,
TFRC 💬 		9件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Phagosome, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬1件: 19 💬
502Tizanidine1件: Tizanidine2件: Tizanidine hydrochloride ,
Tizanidine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
503Tizanidine hydrochloride capsule1件: Tizanidine2件: Tizanidine hydrochloride ,
Tizanidine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
504TJ-68----1件: 2 💬
505TJ0113----1件: 6 💬
506TJ202 injection----1件: 49 💬
507TJ301 300MG----1件: 97 💬
508TJ301 600MG----1件: 97 💬
509TL011----1件: 46 💬
510TL011, anti CD20, FOR THE treatment OF rheumatoid arthritis----1件: 46 💬
511TLL-018----1件: 46 💬
512TLL018----1件: 97 💬
513Tllsh2910----1件: 17 💬
514TM56141件: TM5614---2件: 51, 238 💬
515TMB-001----1件: 160 💬
516TMI-005----1件: 46 💬
517TMP1件: TMP---1件: 299 💬
518TMP001----1件: 13 💬
519TN-2011件: TN-201---1件: 58 💬
520TNB-383B1件: TNB-383B---1件: 28 💬
521TNF alpha----1件: 271 💬
522TNF alpha blockers----1件: 46 💬
523TNF alpha inhibitors----1件: 46 💬
524TNF antagonist----1件: 46 💬
525TNF blockers monotherapy----1件: 46 💬
526TNF inhibitor----3件: 46, 97, 107 💬
527TNF inhibitor/TCZ----1件: 46 💬
528TNF inhibitors----2件: 46, 97 💬
529TNF kinoid----2件: 46, 96 💬
530TNF start----1件: 46 💬
531TNF-A antagonists, NON-tnfs, dmard NON-biologics----3件: 46, 97, 271 💬
532TNF-A inhibitor or JAK inhibitor----1件: 46 💬
533TNF-alpha antagonist and other biotherapy----1件: 46 💬
534TNF-alpha antagonists----3件: 46, 96, 271 💬
535TNF-alpha inhibitor----1件: 46 💬
536TNF-blockers suspension IN patients with rheumatoid arthritis----1件: 46 💬
537TNF-inhibition----1件: 271 💬
538TNF-K----2件: 46, 96 💬
539TNF-kinoid----2件: 46, 96 💬
540Tnfa antagonist - adalimumab----1件: 96 💬
541Tnfa antagonist - infliximab----1件: 96 💬
542Tnfa kinoid----2件: 46, 96 💬
543TNFA-kinoid----1件: 96 💬
544Tnfi----1件: 46 💬
545Tnfi (tumor necrosis factor inhibitor) medication----1件: 107 💬
546Tnfr:FC----3件: 46, 107, 271 💬
547TNR-001----2件: 46, 271 💬
548TNR-001, tnfr:FC----1件: 271 💬
549Tnse----1件: 299 💬
550TNT009----1件: 61 💬
551TNX-650, rhumab ANTI-IL13, AIL-13, MILR1444A----1件: 85 💬
552TO BE confirmed----3件: 46, 65, 97 💬
553TO BE determined----2件: 96, 113 💬
554TO BE requested----2件: 96, 97 💬
555Tobacco questionnaire1件: Tobacco leaf---1件: 299 💬
556Tobacco treatment specialist (TTS) intervention1件: Tobacco leaf---1件: 299 💬
557Tobi1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
558Tobi 300 MG / 5 ML nebuliser solution1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
559Tobi 300 MG/5 ML Lösung FüR einen1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
560Tobi 300 MG/5 ML Lösung FüR einen vernebler1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
561Tobi 300 MG/5 ML nebuliser solution1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
562Tobi 300 MG/5 ML solucióN para inhalacióN POR nebulizador1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
563Tobi 300 MG/5 ML, solution pour inhalation PAR Nébuliseur1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
564Tobi 300MG/ 5ML solucióN para inhalacióN CON nebulizador1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
565Tobi 300MG/5ML nebuliser solution1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
566Tobi inhalant product----1件: 299 💬
567Tobi nebcinal----1件: 299 💬
568Tobi podhaler1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
569Tobi podhaler 28 MG hartkapseln MIT pulver ZUR inhalation1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
570Tobi podhaler 28 MG inhaláCIóS POR, KEMéNY kapszula1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
571Tobi podhaler*448CPS 28MG+10IN1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
572Tobi*nebul 56F 1D 300MG/5ML1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
573Tobi™ podhaler™ 112 MG inhaled twice daily----1件: 299 💬
574Tobramcyin----1件: 299 💬
575Tobramicina1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
576Tobramicina E desametasone DOC generici1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 90 💬
577Tobramicina polvere inalatoria1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
578Tobramicina solfato1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
579Tobramicyn----1件: 299 💬
580Tobramycin1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
581Tobramycin / bramitob1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
582Tobramycin / tobi1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
583Tobramycin 100 pari1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
584Tobramycin DRY powder1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
585Tobramycin FOR inhalation1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
586Tobramycin inhalation powder1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
587Tobramycin inhalation solution1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
588Tobramycin injection 40MG/1ML1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
589Tobramycin nebulized nasally1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
590Tobramycin powder1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
591Tobramycin solution FOR inhalation1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
592Tobramycin solution FOR inhalation 300 MG1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
593Tobramycin steri-NEB 300 MG/5 ML, inhalation solution1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
594Tobramycin sulfate1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
595Tobramycin time OF administration1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
596Tobramycine1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
597Tobramycinum1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬 		--1件: 299 💬
598Tobrineb/bramitob----1件: 299 💬
599Tocilizmab----1件: 46 💬
600Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬24件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
601Tocilizumab 162 MG1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
602Tocilizumab 162MG/0.9ML autoinjector1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
603Tocilizumab 162MG/0.9ML jeringa SC1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
604Tocilizumab 162MG/0.9ML SC PFS SC1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
605Tocilizumab 162MG/0.9ML syringe SC1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
606Tocilizumab and IV steroids combination1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
607Tocilizumab injectable product1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 11 💬
608Tocilizumab injection1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 11, 13 💬
609Tocilizumab injection 8MG/KG1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
610Tocilizumab IV1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
611Tocilizumab or sarilumab2件: Sarilumab,
Tocilizumab		2件: Tocilizumab ,
Sarilumab 💬 		1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
612Tocilizumab plus methotrexate2件: Methotrexate,
Tocilizumab		3件: Methotrexate ,
Methotrexate sodium ,
Tocilizumab 💬 		3件: DHFR,
DHFR,
IL6R 💬 		14件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Folate biosynthesis, Folate transport and metabolism, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
613Tocilizumab prefilled syringe1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 41, 46 💬
614Tocilizumab roche1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
615Tocilizumab SC1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬3件: 41, 46, 107 💬
616Tocilizumab treatment1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
617Tocilizumabum----1件: 46 💬
618Tociluzumab----1件: 65 💬
619Tocoferol1件: Tocopherol1件: Tocopherol 💬 --1件: 90 💬
620Tocopherol1件: Tocopherol1件: Tocopherol 💬 --2件: 257, 298 💬
621Tocopherol acetate2件: Tocopherol,
alpha-Tocopherol acetate		2件: Tocopherol acetate ,
Tocopherol 💬 		--1件: 49 💬
622Tocopheryl acetate1件: alpha-Tocopherol acetate1件: Tocopherol acetate 💬 --1件: 206 💬
623Tocotrienols----1件: 2 💬
624Tofacinitib----1件: 97 💬
625Tofacitinb----1件: 46 💬
626Tofacitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
627Tofacitinib (xeljanz®) 11MG prolonged release tablet1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
628Tofacitinib 10 MG1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 271 💬
629Tofacitinib 2 MG1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 271 💬
630Tofacitinib 5 MG1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬5件: 11, 40, 46, 50, 271 💬
631Tofacitinib 5 MG twice daily1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 84 💬
632Tofacitinib 5MG [xeljanz] 1 year OPEN-label extension1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84 💬
633Tofacitinib 5MG oral tablet [xeljanz] 16 week trial1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84 💬
634Tofacitinib 5MG PO BID1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
635Tofacitinib citrate1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬5件: 46, 49, 97, 107, 271 💬
636Tofacitinib citrate CP-6905501件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
637Tofacitinib citrate tablets1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 271 💬
638Tofacitinib or baricitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
639Tofacitinib plus mesalamine1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
640Tofacitinib tablet1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 40 💬
641Tofacitinib tablets1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 2 💬
642Tofacitinib with methotrexate1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
643Tofacitinib without methotrexate1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
644Tofacitinib XR1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 271 💬
645Tofacitinib/baricitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
646Tofacitinibe citrate----1件: 107 💬
647Tofersen1件: Tofersen1件: Tofersen 💬 1件: SOD1 💬 8件: Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬1件: 2 💬
648Tolasure topical GEL----1件: 36 💬
649Tolcapon1件: Tolcapone1件: Tolcapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
650Tolcapone1件: Tolcapone1件: Tolcapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬3件: 6, 28, 127 💬
651Toldc----1件: 46 💬
652Toldc - intradermal----1件: 13 💬
653Toldc - intranodal----1件: 13 💬
654Toldcb29----1件: 46 💬
655Tolebrutinib1件: Tolebrutinib1件: Tolebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 11, 13 💬
656Tolebrutinib 120MG1件: Tolebrutinib1件: Tolebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
657Tolebrutinib 60MG1件: Tolebrutinib1件: Tolebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
658Tolebrutininb----1件: 11 💬
659Tolerogenic dendritic cells----2件: 46, 96 💬
660Tolerogenic dendritic cells loaded with myelin peptides----1件: 13 💬
661Tolerogenic fibroblasts----1件: 13 💬
662Tolfenamic acid1件: Tolfenamic acid1件: Tolfenamic acid 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 5 💬
663Tolicizumab----1件: 46 💬
664Tolicizumab roche----1件: 46 💬
665Tollb-001 tablets----1件: 46 💬
666Tolperisone HC11件: Tolperisone2件: Tolperisone hydrochloride ,
Tolperisone 💬 		--1件: 13 💬
667Tolperisone HCL1件: Tolperisone2件: Tolperisone hydrochloride ,
Tolperisone 💬 		--1件: 13 💬
668Tolpersan----1件: 13 💬
669Tolposan----1件: 13 💬
670Tolterodine1件: Tolterodine2件: Tolterodine ,
Tolterodine tartrate 💬 		1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 17 💬
671Tolubuterol hydrochloride----1件: 6 💬
672Tolvaptan1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬4件: 67, 72, 86, 225 💬
673Tolvaptan 151件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
674Tolvaptan 15 MG tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
675Tolvaptan 15 MG tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
676Tolvaptan 15MG1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
677Tolvaptan 301件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
678Tolvaptan 30 MG tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
679Tolvaptan 30 MG tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
680Tolvaptan 30MG1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
681Tolvaptan 45/151件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
682Tolvaptan 50MG granules1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
683Tolvaptan 60/301件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
684Tolvaptan 7.5 MG tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
685Tolvaptan IN euvolemic hyponatremia1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
686Tolvaptan IR1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
687Tolvaptan MR1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
688Tolvaptan oral tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
689Tolvaptan suspension1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
690Tolvaptan tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
691Tominersen1件: Tominersen1件: Tominersen 💬 1件: HD 💬 2件: Huntington disease, Pathways of neurodegeneration - multiple diseases 💬1件: 8 💬
692Tominersen 100 MG1件: Tominersen1件: Tominersen 💬 1件: HD 💬 2件: Huntington disease, Pathways of neurodegeneration - multiple diseases 💬1件: 8 💬
693Tominersen 60 MG1件: Tominersen1件: Tominersen 💬 1件: HD 💬 2件: Huntington disease, Pathways of neurodegeneration - multiple diseases 💬1件: 8 💬
694TOP down treatment IF patient AT high risk----2件: 96, 97 💬
695TOP-down----1件: 96 💬
696TOP-N53 vehicle----1件: 51 💬
697TOP1288----1件: 97 💬
698TOP1288 rectal solution----1件: 97 💬
699Topamax1件: Topiramate1件: Topiramate 💬 36件: CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		53件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 140 💬
700Topical 0.1% sirolimus----1件: 278 💬
701Topical amphimatrix----1件: 51 💬
702Topical beremagene geperpavec1件: Beremagene geperpavec1件: Beremagene geperpavec 💬 1件: COL7A 💬 2件: Cornified envelope formation, Protein digestion and absorption 💬1件: 36 💬
703Topical BPM31510 3.0% cream----1件: 36 💬
704Topical calcipotriene 0.005% ointment----1件: 51 💬
705Topical compound tripterygium----1件: 46 💬
706Topical garamycin cream----2件: 35, 162 💬
707Topical infliximab----3件: 38, 39, 162 💬
708Topical opiod----1件: 36 💬
709Topical organogel with nitroglycerin----1件: 51 💬
710Topical preparation H ARM----1件: 13 💬
711Topical rapamycin----1件: 157 💬
712Topical timolol maleate----1件: 227 💬
713Topical tripterygium GEL----1件: 46 💬
714Topical vehicle----1件: 278 💬
715Topimarate----1件: 144 💬
716Topimarato----1件: 144 💬
717Topiramate1件: Topiramate1件: Topiramate 💬 36件: CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		53件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 140, 144, 156, 193 💬
718Topotecan1件: Topotecan2件: Topotecan hydrochloride ,
Topotecan 💬 		--1件: 25 💬
719Torcetrapib/atorvastatin1件: Torcetrapib1件: Torcetrapib 💬 1件: CETP 💬 1件: Cholesterol metabolism 💬1件: 79 💬
720Torvast*10CPR 10MG----1件: 13 💬
721Total body 200CGY----1件: 65 💬
722Total body irradiation----13件: 19, 20, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284, 285 💬
723Total body irradiation 1200 CGY----1件: 60 💬
724Total body irradiation 200 CGY----1件: 60 💬
725Total body irradiation with marrow boosting----2件: 19, 234 💬
726Total body magnetic resonance imaging----1件: 77 💬
727Total dietary replacement----1件: 265 💬
728Total glucosides paeony capsules----1件: 271 💬
729Total lymphoid irradiation----3件: 65, 284, 326 💬
730Total thyroidectomy----1件: 235 💬
731Total-body irradiation----9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
732Tovaxin----1件: 13 💬
733Tovaxin autologous T cell vaccine----1件: 13 💬
734Toxicity, pharmacokinetics----1件: 34 💬
735TOZ----1件: 6 💬
736Tozadenant1件: Tozadenant1件: Tozadenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
737Tozadenant (SYN115) 120 MG BID1件: Tozadenant1件: Tozadenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
738Tozadenant (SYN115) 180 MG BID1件: Tozadenant1件: Tozadenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
739Tozadenant (SYN115) 240 MG BID1件: Tozadenant1件: Tozadenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
740Tozadenant (SYN115) 60 MG BID1件: Tozadenant1件: Tozadenant 💬 1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
741Tozinameran1件: Tozinameran1件: Tozinameran 💬 --1件: 299 💬
742TP04hn106----1件: 2 💬
743TP05----1件: 97 💬
744TP05 coating A----1件: 97 💬
745TP05 coating B----1件: 97 💬
746TP05 coating D----1件: 97 💬
747TP05 coating E----1件: 97 💬
748TP05 coating H----1件: 97 💬
749TPI 287 2 MG/M2----2件: 5, 7 💬
750TPI-287 20 MG/M21件: TPI-287---2件: 5, 7 💬
751TPI-287 6.3 MG/M21件: TPI-287---2件: 5, 7 💬
752TPM203----1件: 35 💬
753Tpmt genotyping----2件: 96, 97 💬
754TPN-101----3件: 2, 127, 325 💬
755TPN-101, 100 MG/DAY----1件: 5 💬
756TPN-101, 200 MG/DAY----1件: 5 💬
757TPN-101, 400 MG/DAY----3件: 2, 5, 127 💬
758TPN171H----1件: 86 💬
759TPN171H single dose----1件: 86 💬
760TPO----1件: 63 💬
761TPO-RA----1件: 63 💬
762TPO-RAS combining ANTI-CD 20 monoclonal antibody----1件: 63 💬
763TQA3526----1件: 93 💬
764TQB3473 tablets----1件: 63 💬
765TQB3702 tablets----1件: 49 💬
766TQH2929 injection----1件: 37 💬
767TQH3821 tablets----1件: 46 💬
768TQH3821 tablets 200 MG----1件: 46 💬
769TQH3906 capsules----2件: 96, 97 💬
770TR-012001----1件: 6 💬
771TR02----1件: 299 💬
772TR0311----1件: 85 💬
773Trabectedina1件: Trabectedin1件: Trabectedin 💬 --1件: 159 💬
774Trabectedine----1件: 159 💬
775Traclear----1件: 86 💬
776Tracleer1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
777Tracleer tablet FOR oral suspension1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
778Tracleer*56CPR RIV 125MG1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
779Trade name xarelto1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 49 💬
780Traditional antirheumatic drugs----1件: 46 💬
781Traditional balance exercises1件: Isoxaflutole---1件: 13 💬
782Traditional treatment OF CGD and TB----1件: 65 💬
783Traditional treatments----1件: 97 💬
784Trafermin1件: Trafermin1件: Trafermin 💬 --1件: 47 💬
785Training groupe----1件: 13 💬
786Tralesinidase alfa1件: Tralesinidase alfa---1件: 19 💬
787Tralokinumab1件: Tralokinumab1件: Tralokinumab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬2件: 85, 97 💬
788Tralokinumab cohort 11件: Tralokinumab1件: Tralokinumab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
789Tralokinumab cohort 21件: Tralokinumab1件: Tralokinumab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
790Tramadol1件: Tramadol2件: Tramadol hydrochloride ,
Tramadol 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 226 💬
791Tramadol /acetaminophen1件: Tramadol2件: Tramadol hydrochloride ,
Tramadol 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 271 💬
792Tramadol hydrochloride + acetaminophen1件: Tramadol2件: Tramadol hydrochloride ,
Tramadol 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
793Tramadol with ropivacaine2件: Ropivacaine,
Tramadol		4件: Tramadol hydrochloride ,
Ropivacaine hydrochloride ,
Ropivacaine ,
Tramadol 💬 		6件: OPRM1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		8件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬1件: 70 💬
794Trametinib1件: Trametinib2件: Trametinib ,
Trametinib dimethyl sulfoxide 💬 		2件: MAP2K1,
MAP2K2 💬 		88件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬2件: 2, 34 💬
795Trametinib tablet1件: Trametinib2件: Trametinib ,
Trametinib dimethyl sulfoxide 💬 		2件: MAP2K1,
MAP2K2 💬 		88件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬4件: 58, 195, 279, 280 💬
796Trancopal dolo----1件: 13 💬
797Tranexamic acid1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬8件: 46, 65, 70, 215, 227, 274, 288, 299 💬
798Tranexamic acid 100 MG/ML1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 70 💬
799Tranilast1件: Tranilast1件: Tranilast 💬 --4件: 46, 84, 106, 113 💬
800Transabdominal ultrasound----1件: 28 💬
801Transcon CNP1件: ACP-015---1件: 276 💬
802Transcon CNP 3.9 MG CNP-38/vial1件: ACP-015---1件: 276 💬
803Transcon PTH1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
804Transcon PTH HIGH-dose PEN1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
805Transcon PTH LOW-dose PEN1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
806Transcon PTH MID-dose PEN1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
807Transcranial magnetic stimulation----3件: 6, 13, 77 💬
808Transcriptomic analysis----2件: 50, 97 💬
809Transcutaneous electrical vagus nerve stimulation----1件: 46 💬
810Transdermal estrogen----1件: 299 💬
811Transdermal fentanyl matrix, gabapentin----1件: 70 💬
812Transdermal nicotine----1件: 6 💬
813Transdermal testosterone GEL----1件: 78 💬
814Transdihydrolisuride----2件: 51, 86 💬
815Transduced CD34+ cells----1件: 285 💬
816Transduced CD34+ hematopoietic stem cell----2件: 19, 20 💬
817Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with A COL17a1-encoding retroviral vector----1件: 36 💬
818Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with A COL7a1-encoding retroviral vector----1件: 36 💬
819Transforaminal epidural injection----1件: 70 💬
820Transfusion----1件: 96 💬
821Translarna1件: Ataluren1件: Ataluren 💬 --1件: 113 💬
822Translarna 1000 MG granules FOR oral suspension1件: Ataluren1件: Ataluren 💬 --1件: 113 💬
823Translarna 125 MG granules FOR oral suspension1件: Ataluren1件: Ataluren 💬 --1件: 113 💬
824Translarna 250 MG granules FOR oral suspension1件: Ataluren1件: Ataluren 💬 --1件: 113 💬
825Transnasal butterfly surgery----1件: 77 💬
826Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy----1件: 74 💬
827Transorbital ultrasound----1件: 41 💬
828Transplant preparative regimen OF alemtuzumab, fludarabine, thiotepa, and melphalan----2件: 65, 164 💬
829Transplantation----1件: 36 💬
830Transsphenoidal adenomectomy----1件: 77 💬
831Transsphenoidal surgery----1件: 77 💬
832Transsphenoidal surgery treatment----1件: 74 💬
833Transthoracic echocardiographic----1件: 46 💬
834Transvaginal botulinum toxin A (BTA) injection----1件: 226 💬
835Trap myelin test----1件: 13 💬
836Trappa ethanolamine tablets----1件: 60 💬
837Trappsol cyclo----1件: 19 💬
838Traxoprodil1件: Traxoprodil---1件: 6 💬
839Trazodone hydrochloride oral solution1件: Trazodone2件: Trazodone hydrochloride ,
Trazodone 💬 		4件: HTR2,
HTR2,
HTR2,
SLC6A4 💬 		7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 2 💬
840TRE----1件: 86 💬
841Treat TO target----1件: 46 💬
842Treat with lansoprazole 30 MG BID FOR 2 weeks, endoscopic examination with esophageal biopsy FOR patients with persistent symptoms----1件: 98 💬
843Treatment----2件: 41, 299 💬
844Treatment : H. pylori eradication----1件: 63 💬
845Treatment :abacavir 600 MG/lamivudine 300 MG----1件: 49 💬
846Treatment A----2件: 34, 46 💬
847Treatment according TO current standards without knowledge OF serum infliximab and ANTI-infliximab AB status----1件: 96 💬
848Treatment algorithm A----1件: 97 💬
849Treatment algorithm B----1件: 97 💬
850Treatment algorithm C----1件: 97 💬
851Treatment B----2件: 34, 46 💬
852Treatment BX1514M----1件: 58 💬
853Treatment C----2件: 34, 46 💬
854Treatment D----1件: 34 💬
855Treatment defined only BY active substance----1件: 50 💬
856Treatment group: rectal instillation OF qhqyp----1件: 97 💬
857Treatment I----1件: 46 💬
858Treatment II----1件: 46 💬
859Treatment III----1件: 46 💬
860Treatment intervention----1件: 61 💬
861Treatment OF MTX and HCQ----1件: 46 💬
862Treatment OF MTX and twhf----1件: 46 💬
863Treatment OF TCM----1件: 46 💬
864Treatment OF twhf----1件: 46 💬
865Treatment phase group 4----1件: 113 💬
866Treatment standard----1件: 61 💬
867Treatment taken----1件: 113 💬
868Treatment VS control bread----1件: 97 💬
869Treatment with adalimumab----1件: 96 💬
870Treatment with azathioprin----1件: 95 💬
871Treatment with cystic fibrosis transmembrane regulator (cftr) modualtors ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, elexacaftor-tezacaftor-ivacaftor----1件: 299 💬
872Treatment with mycophenolat mofetil----1件: 95 💬
873Treatment with topical superpotent corticosteroid therapy----1件: 162 💬
874Treatment withdrawal----1件: 13 💬
875Tregalizumab1件: Tregalizumab---1件: 46 💬
876Trehalose1件: Trehalose---3件: 2, 6, 113 💬
877Tremfya1件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 37 💬
878Treosulfan1件: Treosulfan1件: Treosulfan 💬 --6件: 13, 19, 62, 65, 284, 286 💬
879Treprosinil diethanolamine----1件: 86 💬
880Treprostin----1件: 86 💬
881Treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 85, 86, 210 💬
882Treprostinil dietanolamina1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
883Treprostinil diethanolamine1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬2件: 51, 86 💬
884Treprostinil diolamine1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
885Treprostinil inhalation powder1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
886Treprostinil inhalations1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
887Treprostinil injectable product1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
888Treprostinil palmitil2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
889Treprostinil palmitil inhalation powder2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
890Treprostinil palmitil inhalation powder - 160 microgram2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
891Treprostinil palmitil inhalation powder - 320 microgram2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
892Treprostinil palmitil inhalation powder - 80 microgram2件: Treprostinil,
Treprostinil palmitil		4件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine ,
Treprostinil palmitil 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
893Treprostinil sodium1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 51, 86, 88 💬
894Treprostinil sodium FOR inhalation1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 85 💬
895Treprostinil sodium solution FOR inhalation1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
896Treprostinil sodium, UT-151件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
897Treprostinil ultrasonic nebulizer1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 85 💬
898Treprostinil VIA implanted pump1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
899Treprostinil, UT-15, LRX-15, 15au81, BW A15AU, U-62, 8401件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
900Tretinoin1件: Tretinoin1件: Tretinoin 💬 3件: PML,
RARA,
RARB 💬 		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬3件: 62, 63, 75 💬
901Tretinoin and pioglitazone HCL2件: Pioglitazone,
Tretinoin		3件: Tretinoin ,
Pioglitazone hydrochloride ,
Pioglitazone 💬 		4件: NR1C3,
PML,
RARA,
RARB 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Efferocytosis, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 2 💬
902Tretinoina1件: Tretinoin1件: Tretinoin 💬 3件: PML,
RARA,
RARB 💬 		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 75 💬
903Trexan----1件: 46 💬
904Trexan INJ 25 MG/ML----1件: 97 💬
905Trexan+salazopyrin+oxiklorin+prednisolone + infliximab1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
906TRH----1件: 80 💬
907TRI-O-acetyluridine1件: Uridine triacetate1件: Uridine triacetate 💬 --1件: 21 💬
908Triac----1件: 139 💬
909Triam 40 MG lichtenstein----1件: 46 💬
910Triamcinolonacetonid EP----1件: 46 💬
911Triamcinolone1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬6件: 46, 53, 90, 96, 226, 298 💬
912Triamcinolone acetonide1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 35, 46, 56 💬
913Triamcinolone acetonide and normal saline solution1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 70 💬
914Triamcinolone hexacetonide1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 46, 107 💬
915Triamcinolone hexacetonide 20 MG/ML1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 107 💬
916Triangular test----1件: 96 💬
917Triapin& triapin mite----1件: 19 💬
918Triatec----1件: 113 💬
919Tributyrin1件: Tributyrin---1件: 6 💬
920Tricaprilin1件: Tricaprylin1件: Tricaprilin 💬 --1件: 145 💬
921Trichuris suis eggs----3件: 13, 96, 97 💬
922Trichuris suis OVA----4件: 13, 46, 96, 97 💬
923Trichuris suis OVA (eggs), embryonated, viable----1件: 13 💬
924Trichuris trichiura eggs----1件: 96 💬
925Tridecanoic acid----1件: 156 💬
926Trientine1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--2件: 58, 171 💬
927Trientine dihydrochloride1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--2件: 58, 171 💬
928Trientine dihydrochloride 300MG capsules1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
929Trientine tetrahydrochloride1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
930Triethylenetetramine dihydrochloride1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
931Triethylinetetramine dihydrochloride----1件: 58 💬
932Trifakta----1件: 299 💬
933Trifluoperazine1件: Trifluoperazine3件: Trifluoperazine hydrochloride ,
Trifluoperazine maleate ,
Trifluoperazine 💬 		1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 283, 284 💬
934Trigel----1件: 6 💬
935Triheptanoin1件: Triheptanoin1件: Triheptanoin 💬 --10件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
936Triheptanoin / triheptanoina1件: Triheptanoin1件: Triheptanoin 💬 --1件: 248 💬
937Triheptanoin 1G/KG/DAY1件: Triheptanoin1件: Triheptanoin 💬 --1件: 8 💬
938Triheptanoin OIL1件: Triheptanoin1件: Triheptanoin 💬 --1件: 8 💬
939Triheptanoina----1件: 248 💬
940Trihexyphenidyl1件: Trihexyphenidyl2件: Trihexyphenidyl hydrochloride ,
Trihexyphenidyl 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 5, 6 💬
941Trikafta3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬 		1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
942Trilac----2件: 96, 97 💬
943Trileptal1件: Oxcarbazepine1件: Oxcarbazepine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
944Trimebutine1件: Trimebutine2件: Trimebutine maleate ,
Trimebutine 💬 		2件: OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 51 💬
945Trimetazidine1件: Trimetazidine2件: Trimetazidine hydrochloride ,
Trimetazidine 💬 		--3件: 2, 58, 86 💬
946Trimetazidine dihydrochloride1件: Trimetazidine2件: Trimetazidine hydrochloride ,
Trimetazidine 💬 		--1件: 2 💬
947Trimetazidine dihydrochloride 20MG1件: Trimetazidine2件: Trimetazidine hydrochloride ,
Trimetazidine 💬 		--1件: 58 💬
948Trimethaphan1件: Trimethaphan---1件: 17 💬
949Trimethobenzamide1件: Trimethobenzamide2件: Trimethobenzamide hydrochloride ,
Trimethobenzamide 💬 		--1件: 6 💬
950Trimethobenzamide hydrochloride1件: Trimethobenzamide2件: Trimethobenzamide hydrochloride ,
Trimethobenzamide 💬 		--1件: 6 💬
951Trimethoprim1件: Trimethoprim3件: Trimethoprim ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--3件: 36, 85, 299 💬
952Trimethoprim and sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		4件: Trimethoprim ,
Sulfamethoxazole ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--1件: 299 💬
953Trimethoprim sulfamethoxazole1件: Trimethoprim3件: Trimethoprim ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--1件: 44 💬
954Trimethoprim sulfate1件: Trimethoprim3件: Trimethoprim ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--1件: 60 💬
955Trimethoprim-sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		4件: Trimethoprim ,
Sulfamethoxazole ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--3件: 49, 61, 299 💬
956Trimethoprim/sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		4件: Trimethoprim ,
Sulfamethoxazole ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--1件: 299 💬
957Trimeton - 10 MG/1 ML soluzione iniettabile 5 fiale 1 ML----1件: 14 💬
958Trimetoprim----1件: 299 💬
959Triple combination therapy----1件: 299 💬
960Triple therapy----2件: 50, 63 💬
961Triple-combination therapy----1件: 86 💬
962Triplet-primed PCR or LONG-read sequencing----1件: 113 💬
963Tripterygium1件: Tripterygium wilfordii whole---4件: 66, 162, 224, 271 💬
964Tripterygium glycosides1件: Tripterygium wilfordii whole---1件: 96 💬
965Tripterygium wilfordii1件: Tripterygium wilfordii whole---3件: 46, 67, 222 💬
966Tripterygium wilfordii hook F1件: Tripterygium wilfordii whole---1件: 46 💬
967Tripterygium wilfordii polyglycosidium1件: Tripterygium wilfordii whole---1件: 224 💬
968Triptolide-containing formulation1件: Triptolide---1件: 67 💬
969Triptorelin1件: Triptorelin3件: Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
970Triptorelin acetate and gonadorelin acetate2件: Gonadorelin,
Triptorelin		6件: Gonadorelin hydrochloride ,
Gonadorelin acetate ,
Triptorelin ,
Triptorelin pamoate ,
Gonadorelin ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
971Triptorelin embonate, triptorelin pamoate1件: Triptorelin3件: Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
972Triptorelin pamoate1件: Triptorelin3件: Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 49, 76 💬
973Triptorelin pamoate 15MG1件: Triptorelin3件: Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
974Triptorlin or leuprorelin----1件: 76 💬
975Tris1件: Tromethamine1件: Tromethamine 💬 --2件: 96, 97 💬
976Trisequens----1件: 78 💬
977Triterpene DRY extract from birch cork----1件: 36 💬
978Triumeq3件: Abacavir,
Dolutegravir,
Lamivudine		5件: Lamivudine ,
Abacavir sulfate ,
Abacavir ,
Dolutegravir ,
Dolutegravir sodium 💬 		--1件: 2 💬
979Trivalent chromium versus synthetic and/ or biological dmards----1件: 46 💬
980Trivalent inactivated influenza vaccine----1件: 46 💬
981Trivalent seasonal influenza vaccine----1件: 13 💬
982Trivastal----1件: 6 💬
983TRK-100STP----1件: 86 💬
984TRK-170----1件: 96 💬
985TRK-2501件: TRK-250---1件: 85 💬
986TRN501 - dose 1----1件: 6 💬
987TRN501 - dose 2----1件: 6 💬
988TRN501 - dose 3----1件: 6 💬
989TRN501 - dose 4----1件: 6 💬
990TRN501 - dose 5----1件: 6 💬
991TRN501 - dose 6----1件: 6 💬
992TRN501 - dose 7----1件: 6 💬
993TRN501 - dose 8----1件: 6 💬
994TRO19622----2件: 2, 3 💬
995Trobalt1件: Ezogabine1件: Ezogabine 💬 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬1件: 2 💬
996Trofinetide1件: Trofinetide1件: Trofinetide 💬 --1件: 156 💬
997Tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 19 💬
998Tropifexor1件: Tropifexor1件: Tropifexor 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
999TRP----3件: 46, 75, 77 💬
1000TRU-0151件: TRU-015---3件: 46, 49, 222 💬
1001Trulicity 0,75 MG injekcný roztok naplnený V injekcnom pere----1件: 13 💬
1002Trunk impairment----1件: 13 💬
1003Trunk impairment scale----1件: 6 💬
1004Trunk position sense----1件: 13 💬
1005Truvada1件: Emtricitabine1件: Emtricitabine 💬 --1件: 265 💬
1006Truxima----1件: 222 💬
1007Truximab----1件: 222 💬
1008TRX0237----1件: 127 💬
1009TRX103----1件: 96 💬
1010Trypsin1件: Trypsin1件: Trypsin, crystallized 💬 --1件: 96 💬
1011Tryptophan1件: Tryptophan1件: Tryptophan 💬 --1件: 46 💬
1012Tryptophan (TRP) depletion1件: Tryptophan1件: Tryptophan 💬 --1件: 6 💬
1013TS-152----1件: 46 💬
1014TSHA-1011件: TSHA-101---1件: 19 💬
1015TSHA-1021件: TSHA-102---1件: 156 💬
1016TSO----3件: 13, 46, 97 💬
1017TSO 250----1件: 96 💬
1018TSO 2500----1件: 96 💬
1019TSO 7500----1件: 96 💬
1020TT vaccine----1件: 13 💬
1021TTI-0102----1件: 21 💬
1022TTI-1011件: TTI-101---1件: 85 💬
1023TTI-1612----1件: 226 💬
1024TTX-381----1件: 19 💬
1025TU-1001件: TU-100---1件: 96 💬
1026Tuberculin skin test----1件: 46 💬
1027Tudca1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 2 💬
1028Tudcabil----1件: 2 💬
1029Tulisokibart1件: Tulisokibart1件: Tulisokibart 💬 1件: TNFSF15 💬 1件: Cytokine-cytokine receptor interaction 💬3件: 51, 96, 97 💬
1030Tulisokibart 1件: Tulisokibart1件: Tulisokibart 💬 1件: TNFSF15 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 51 💬
1031Tulobuterol hydrochloride1件: Tulobuterol2件: Tulobuterol hydrochloride ,
Tulobuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1032Tumor necrosis factor (TNF)-alpha inhibitors----1件: 97 💬
1033Tumor necrosis factor inhibitors----1件: 46 💬
1034Turmeric1件: Turmeric---3件: 140, 144, 158 💬
1035Tuvusertib1件: Tuvusertib1件: Tuvusertib 💬 1件: ATR 💬 7件: Cell cycle, Cellular senescence, Fanconi anemia pathway, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, p53 signaling pathway 💬1件: 65 💬
1036TV-4710----1件: 49 💬
1037TV-5010----1件: 13 💬
1038TV-5600----3件: 8, 13, 96 💬
1039TV-7110----1件: 2 💬
1040TV-7820----1件: 8 💬
1041TVP-1012----1件: 6 💬
1042TVP-1012 0.5MG----1件: 6 💬
1043TVP-1012 1MG----1件: 6 💬
1044Twhf----1件: 46 💬
1045Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1046Twice-daily dosage with 0.5% cyclosporine-A eyedrops----1件: 90 💬
1047TYK2 inhibitor----1件: 97 💬
1048Tylenol----1件: 70 💬
1049Tylenol pill----1件: 13 💬
1050TYR----3件: 75, 77, 298 💬
1051TYRA-300 0.125 MG/KG----1件: 276 💬
1052TYRA-300 0.25 MG/KG----1件: 276 💬
1053TYRA-300 0.375 MG/KG----1件: 276 💬
1054TYRA-300 0.50 MG/KG----1件: 276 💬
1055Tyramine1件: Tyramine---1件: 6 💬
1056Tyrosine1件: Tyrosine1件: Tyrosine 💬 --2件: 6, 86 💬
1057Tysabri1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬3件: 13, 25, 63 💬
1058Tysabri 300 MG concentrado para solucióN para perfusióN1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1059Tysabri 300 MG concentrate FOR solution FOR infusion1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1060Tysabri 300 MG solution à diluer pour perfusion1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1061Tysabri and avonex----1件: 13 💬
1062Tysabri injectable product----1件: 13 💬
1063Tysabri*IV 1FL 300MG 15ML----1件: 13 💬
1064Tyvaso inhalation solution----1件: 86 💬
1065Tyvaso® (treprostinil) inhalation solution, FOR oral inhalation USE1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 85 💬
1066Téatrois----1件: 139 💬
1067Téralithe LP----1件: 2 💬
1068Tériparatide----1件: 235 💬